Cargando…
Nanofiber-based systems intended for diabetes
Diabetic mellitus (DM) is the most communal metabolic disease resulting from a defect in insulin secretion, causing hyperglycemia by promoting the progressive destruction of pancreatic β cells. This autoimmune disease causes many severe disorders leading to organ failure, lower extremity amputations...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513238/ https://www.ncbi.nlm.nih.gov/pubmed/34641920 http://dx.doi.org/10.1186/s12951-021-01065-2 |
_version_ | 1784583172538761216 |
---|---|
author | Maleki, Hassan Khoshnevisan, Kamyar Sajjadi-Jazi, Sayed Mahmoud Baharifar, Hadi Doostan, Maryam Khoshnevisan, Nazanin Sharifi, Farshad |
author_facet | Maleki, Hassan Khoshnevisan, Kamyar Sajjadi-Jazi, Sayed Mahmoud Baharifar, Hadi Doostan, Maryam Khoshnevisan, Nazanin Sharifi, Farshad |
author_sort | Maleki, Hassan |
collection | PubMed |
description | Diabetic mellitus (DM) is the most communal metabolic disease resulting from a defect in insulin secretion, causing hyperglycemia by promoting the progressive destruction of pancreatic β cells. This autoimmune disease causes many severe disorders leading to organ failure, lower extremity amputations, and ultimately death. Modern delivery systems e.g., nanofiber (NF)-based systems fabricated by natural and synthetic or both materials to deliver therapeutics agents and cells, could be the harbinger of a new era to obviate DM complications. Such delivery systems can effectively deliver macromolecules (insulin) and small molecules. Besides, NF scaffolds can provide an ideal microenvironment to cell therapy for pancreatic β cell transplantation and pancreatic tissue engineering. Numerous studies indicated the potential usage of therapeutics/cells-incorporated NF mats to proliferate/regenerate/remodeling the structural and functional properties of diabetic skin ulcers. Thus, we intended to discuss the aforementioned features of the NF system for DM complications in detail. [Image: see text] |
format | Online Article Text |
id | pubmed-8513238 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-85132382021-10-20 Nanofiber-based systems intended for diabetes Maleki, Hassan Khoshnevisan, Kamyar Sajjadi-Jazi, Sayed Mahmoud Baharifar, Hadi Doostan, Maryam Khoshnevisan, Nazanin Sharifi, Farshad J Nanobiotechnology Review Diabetic mellitus (DM) is the most communal metabolic disease resulting from a defect in insulin secretion, causing hyperglycemia by promoting the progressive destruction of pancreatic β cells. This autoimmune disease causes many severe disorders leading to organ failure, lower extremity amputations, and ultimately death. Modern delivery systems e.g., nanofiber (NF)-based systems fabricated by natural and synthetic or both materials to deliver therapeutics agents and cells, could be the harbinger of a new era to obviate DM complications. Such delivery systems can effectively deliver macromolecules (insulin) and small molecules. Besides, NF scaffolds can provide an ideal microenvironment to cell therapy for pancreatic β cell transplantation and pancreatic tissue engineering. Numerous studies indicated the potential usage of therapeutics/cells-incorporated NF mats to proliferate/regenerate/remodeling the structural and functional properties of diabetic skin ulcers. Thus, we intended to discuss the aforementioned features of the NF system for DM complications in detail. [Image: see text] BioMed Central 2021-10-12 /pmc/articles/PMC8513238/ /pubmed/34641920 http://dx.doi.org/10.1186/s12951-021-01065-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Maleki, Hassan Khoshnevisan, Kamyar Sajjadi-Jazi, Sayed Mahmoud Baharifar, Hadi Doostan, Maryam Khoshnevisan, Nazanin Sharifi, Farshad Nanofiber-based systems intended for diabetes |
title | Nanofiber-based systems intended for diabetes |
title_full | Nanofiber-based systems intended for diabetes |
title_fullStr | Nanofiber-based systems intended for diabetes |
title_full_unstemmed | Nanofiber-based systems intended for diabetes |
title_short | Nanofiber-based systems intended for diabetes |
title_sort | nanofiber-based systems intended for diabetes |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513238/ https://www.ncbi.nlm.nih.gov/pubmed/34641920 http://dx.doi.org/10.1186/s12951-021-01065-2 |
work_keys_str_mv | AT malekihassan nanofiberbasedsystemsintendedfordiabetes AT khoshnevisankamyar nanofiberbasedsystemsintendedfordiabetes AT sajjadijazisayedmahmoud nanofiberbasedsystemsintendedfordiabetes AT baharifarhadi nanofiberbasedsystemsintendedfordiabetes AT doostanmaryam nanofiberbasedsystemsintendedfordiabetes AT khoshnevisannazanin nanofiberbasedsystemsintendedfordiabetes AT sharififarshad nanofiberbasedsystemsintendedfordiabetes |